Valuation: Biogen Inc.

Market Cap 30.37B 26.58B 24.49B 22.7B 43.09B 2,882B 43.79B 294B 114B 1,422B 114B 112B 4,917B P/E 2026 *
31.3x
P/E 2027 * 17.2x
Enterprise Value 35.88B 31.4B 28.94B 26.82B 50.91B 3,405B 51.73B 347B 135B 1,680B 135B 132B 5,808B EV / Sales 2026 *
3.57x
EV / Sales 2027 * 3.25x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day-3.05%
1 week-4.75%
Current month-7.54%
1 month+3.71%
3 months+11.05%
6 months+7.40%
Current year+13.51%
1 week 199.29
Extreme 199.29
219.02
1 month 193.2
Extreme 193.195
219.72
Current year 160.36
Extreme 160.3645
219.72
1 year 121.05
Extreme 121.05
219.72
3 years 110.04
Extreme 110.035
282.74
5 years 110.04
Extreme 110.035
372.12
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
09/06Free

Chairman

2,005 0.0014%
09/06Fiscal year

Director

6,245 0.0042%
09/06Free

Director

1,505 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-3.05%-4.75%+48.57%-29.05% 30.37B
-2.04%+6.22%+21.15%-5.65% 68.8B
-2.01%-3.57%+46.21%+217.06% 55.21B
-4.15%+36.30%+36.30%+36.30% 43.46B
+0.27%+8.33%-49.87%-53.43% 41.18B
-7.20%+2.30%+127.92%-39.75% 31.65B
-0.98%+2.48%+72.35%+88.45% 23.58B
-1.15%+8.29%+4.42%+184.96% 19.33B
-1.33%+1.11%+66.11%+131.83% 17.16B
-1.63%+2.31%+76.52%+339.17% 15.27B
Average -2.33%+3.83%+44.97%+86.99% 34.6B
Weighted average by Cap. -2.41%+3.59%+38.00%+63.39%

Financials

2026 *2027 *
Net sales 10.05B 8.8B 8.11B 7.51B 14.26B 954B 14.49B 97.19B 37.8B 471B 37.73B 36.92B 1,627B 10.39B 9.09B 8.38B 7.76B 14.74B 986B 14.97B 100B 39.06B 486B 38.99B 38.15B 1,681B
Net income 1.52B 1.33B 1.23B 1.14B 2.16B 144B 2.19B 14.72B 5.72B 71.3B 5.71B 5.59B 246B 1.97B 1.72B 1.59B 1.47B 2.79B 187B 2.84B 19.04B 7.4B 92.22B 7.39B 7.23B 319B
Net Debt 5.51B 4.82B 4.44B 4.12B 7.82B 523B 7.94B 53.27B 20.72B 258B 20.68B 20.23B 892B 3.38B 2.96B 2.73B 2.53B 4.8B 321B 4.88B 32.73B 12.73B 159B 12.71B 12.43B 548B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
09/07/26 USD 201.75 -1.92% 820,008
07/07/26 USD 205.70 -1.32% 1,156,880
06/07/26 USD 208.46 -3.54% 1,218,492
02/07/26 USD 216.12 +3.04% 1,155,165
01/07/26 USD 209.74 -2.93% 1,138,639
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
205.70USD
Average target price
222.38USD
Spread / Average Target
+8.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock